Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH, 100mg

3-(DIBUTYLAMINO)PROPYL 4-HYDROXYBENZOATE (HCL), 95%, 5g

5'-O-(4,4'-DIMETHOXYTRITYL)URIDINE, 95%, 1g

1-((3,4-Dimethoxyphenethyl)amino)-3-(m-tolyloxy)propan-2-ol hydrochloride, 98.0%, 5g

Accesorios bloque intercambiable para vasos de muestra, Gesch. para 24 vasos de muestra 15,0 mm x P 30 mm, fondo plano, 1 pieza

1-Boc-2-Butylpiperazine hydrochloride, 95.0%, 250mg

3,4-Dichloro-5-nitrobenzotrifluoride, 97.0%, 10g

2,4,4-Trimethyl-3-oxopentanenitrile, 95%, 1g

all cis-5,8,11,14,17-Eicosapentaenoic Acid>95.0%(GC)100mg

2-BROMO-6-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 95.0%, 1g

(R)-tert-butyl 2-(1-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoyl)-3-hydroxyazetidin-3-yl)piperidine-1-carboxylate, 97%, 250mg

imidazolidine-2,4-dione, >98%, 100g

N-(2-Dimethylaminoethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 250mg